Skip to main content
logo
Exousia Bio, Inc. (LMMY)
OTCMKTS · Delayed Price · Currency is USD
0.1615
0.00 (0.00%)
Aug 20, 2026, 4:00 PM EST

Exousia Bio Ratios and Metrics

Millions USD. Fiscal year is Jun - May.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 May '25 May '24 May '23 May '22
Market Capitalization
82---
Market Cap Growth
505.35%----
Enterprise Value
82---
Last Close Price
0.160.20---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 May '25 May '24 May '23 May '22
PE Ratio
-30.26---
PS Ratio
-414.77---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 May '25 May '24 May '23 May '22
EV/Sales Ratio
-414.50---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 May '25 May '24 May '23 May '22
Debt / Equity Ratio
---1.04-1.96-123.80
Net Debt / Equity Ratio
---1.02-1.69-100.67
Net Debt / EBITDA Ratio
---4.86-1.34-37.31
Asset Turnover
-0.270.36--
Quick Ratio
--0.922.18-
Current Ratio
--0.922.18-
Return on Assets (ROA)
-1.61%-145.17%-50.86%-70.48%-
Return on Capital Employed (ROCE)
-1.30%--197.60%-153.50%-3.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 May '25 May '24 May '23 May '22
Earnings Yield
-0.95%3.30%---
Buyback Yield / Dilution
-33.89%--36.77%-248.82%-